Advertisement

Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond

Published:February 14, 2006DOI:https://doi.org/10.1016/j.biopsych.2005.10.024
      This review summarizes our current understanding of catechol-o-methyltransferase (COMT) and how it relates to brain function and schizophrenia. We begin by considering the COMT gene, its transcripts and proteins, and its relevance for central catecholamine function. We then describe how variation in COMT activity affects the function of the prefrontal cortex (PFC) and associated areas, reviewing evidence that COMT modulates executive function and working memory and highlighting recent data that also implicate it in emotional processing. Finally, we discuss briefly the genetic association between COMT and schizophrenia, focusing in particular on the complex interaction of functional loci within the gene that may underlie the mixed results of studies to date. We conclude by outlining preliminary data indicating that COMT is a promising therapeutic target for ameliorating the cognitive deficits associated with schizophrenia.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Akil M.
        • Kolachana B.S.
        • Rothmond D.A.
        • Hyde T.H.
        • Weinberger D.R.
        • Kleinman J.E.
        Catechol-o-methyltransferase genotype and dopamine regulation in the human brain.
        J Neurosci. 2003; 23: 2008-2013
        • Ameri A.
        The effects of cannabinoids on the brain.
        Prog Neurobiol. 1999; 58: 315-348
        • Avramopoulos D.
        • Stefanis N.C.
        • Hantoumi I.
        • Smyrnis N.
        • Evdokidimis Stefanis C.N.
        Higher scores of self reported schizotypy in healthy young men carrying the COMT high activity allele.
        Mol Psychiatry. 2002; 7: 706-711
        • Axelrod J.
        • Tomchick R.
        Enzymatic o-methylation of epinephrine and other catechols.
        J Biol Chem. 1958; 233: 702-705
        • Badner J.A.
        • Gershon E.S.
        Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia.
        Mol Psychiatry. 2002; 7: 405-411
        • Baker K.
        • Baldeweg T.
        • Sivagnanasundaram S.
        • Scambler P.
        • Skuse D.
        COMT Val108/158Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
        Biol Psychiatry. 2005; 58: 23-31
        • Bassett A.S.
        • Chow E.W.C.
        22q11 deletion syndrome.
        Biol Psychiatry. 1999; 46: 882-891
        • Bassett A.S.
        • Hodgkinson K.
        • Chow E.W.C.
        • Correia S.
        • Scott L.E.
        • Weksberg R.
        22q11 deletion syndrome in adults with schizophrenia.
        Am J Med Genet (Neuropsychiatr Genet). 1998; 81: 328-337
        • Bearden C.E.
        • Jawad A.F.
        • Lynch D.R.
        • Sokol S.
        • Kanes S.J.
        • McDonald-McGinn D.M.
        • et al.
        Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11 deletion syndrome.
        Am J Psychiatry. 2004; 161: 1700-1702
        • Bellgrove M.A.
        • Domschke K.
        • Hawi Z.
        • Kirley A.
        • Mullins C.
        • Robertson I.H.
        • et al.
        The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.
        Exp Brain Res. 2005; 163: 352-360
        • Bertocci B.
        • Miggiano V.
        • Da Prada M.
        • Dembic Z.
        • Lahm H.-W.
        • Malherbe P.
        Human catechol-omethyltransferase.
        Proc Natl Acad Sci U S A. 1991; 88: 1416-1420
        • Bertolino A.
        • Caforio G.
        • Blasi G.
        • De Candia M.
        • Latorre V.
        • Petruzzella V.
        • et al.
        Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
        Am J Psychiatry. 2004; 161: 1798-1805
        • Bilder R.M.
        • Volavka J.
        • Czobor P.
        • Malholtra A.K.
        • Kennedy J.L.
        • Ni X.
        • Goldman R.S.
        • et al.
        Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia.
        Biol Psychiatry. 2002; 52: 701-707
        • Bilder R.M.
        • Volavka J.
        • Lachman H.M.
        • Grace A.A.
        The catechol-o-methyltransferase polymorphism.
        Neuropsychopharmacology. 2004; 29: 1943-1961
        • Blasi G.
        • Mattay V.S.
        • Bertolino A.
        • Elvevåg B.
        • Callicott J.H.
        • Das S.
        • et al.
        Effect of catechol-o-methyltransferase val158met genotype on attentional control.
        J Neurosci. 2005; 25: 5038-5045
        • Borroni B.
        • Agosti C.
        • Archetti S.
        • Costanzi C.
        • Bonomi S.
        • Ghianda D.
        • et al.
        Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer disease.
        Neurosci Lett. 2004; 370: 127-129
        • Bray N.J.
        • Buckland P.R.
        • Williams N.M.
        • Williams H.J.
        • Norton N.
        • Owen M.J.
        • et al.
        A haplotype implicated in schizophrenia is associated with reduced COMT expression in human brain.
        Am J Hum Genet. 2003; 73: 152-161
        • Broch Jr, O.J.
        • Fonnum F.
        The regional and subcellular distribution of catechol-o-methyltransferse in the rat brain.
        J Neurochemistry. 1972; 19: 2049-2055
        • Busch A.E.
        • Karbach U.
        • Miska D.
        • Gorboulev V.
        • Akhoundova A.
        • Volk C.
        • et al.
        Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
        Mol Pharmacol. 1998; 54: 342-352
        • Carr D.B.
        • Sesack S.R.
        Projections from the rat prefrontal cortex to the ventral tegmental area.
        J Neurosci. 2001; 20: 3864-3873
        • Caspi A.
        • Moffitt T.E.
        • Cannon M.
        • McClay J.
        • Murray R.
        • Harrington H.
        • et al.
        Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene.
        Biol Psychiatry. 2005; 57: 1117-1127
        • Ceravolo R.
        • Piccini P.
        • Bailey D.L.
        • Jorga K.M.
        • Bryson H.
        • Brooks D.J.
        18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson’s disease.
        Synapse. 2002; 43: 201-207
        • Chen J.
        • Lipska B.K.
        • Halim N.
        • Ma Q.D.
        • Matsumoto M.
        • Melhem S.
        • et al.
        Functional analysis of genetic variation in catechol-O-methyltransferase (COMT).
        Am J Hum Genet. 2004; 75: 807-821
        • Chen X.
        • Wang X.
        • O’Neill A.F.
        • Walsh D.
        • Kendler K.S.
        Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
        Mol Psychiatry. 2004; 9: 962-967
        • Coon H.
        • Jensen S.
        • Holik J.
        • Hoff M.
        • Myles-Worsley M.
        • Reimherr F.
        • et al.
        Genomic scan for genes predisposing to schizophrenia.
        Am J Med Genet (Neuropsychiatr Genet). 1994; 54: 59-71
        • Diamond A.
        • Briand L.
        • Fossella J.
        • Gehlbach L.
        Genetic and neurochemical modulation of prefrontal cognitive function in children.
        Am J Psychiatry. 2004; 161: 125-132
      1. Drabant EM, Hariri AR, Munoz KE, Meyer-Lindenberg A, Mattay VS, Kolachana BS, et al (in press): Catechol-o-methyltransferase val158met genotype and neural mechanisms of arousal and behavioral regulation. Arch Gen Psychiatry.

        • Egan M.F.
        • Goldberg T.E.
        • Kolachana B.S.
        • Callicott J.H.
        • Mazzanti C.M.
        • Straub R.E.
        • et al.
        Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.
        Proc Natl Acad Sci U S A. 2001; 98: 6917-6922
        • Enoch M.A.
        • Xu K.
        • Ferro E.
        • Harris C.R.
        • Goldman D.
        Genetic origins of anxiety in women.
        Psychiatr Genet. 2003; 13: 33-41
        • Fan J.B.
        • Chen W.Y.
        • Tang J.X.
        • Li S.
        • Gu N.F.
        • Feng G.Y.
        • et al.
        Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population.
        Mol Psychiatry. 2005; 7: 446-452
        • Floderus Y.
        • Ross S.B.
        • Wetterberg L.
        Erythrocyte catechol-o-methyltransferase activity in a Swedish population.
        Clin Genet. 1981; 19: 389-392
        • Foltynie T.
        • Goldberg T.E.
        • Lewis S.G.J.
        • Blackwell A.D.
        • Kolachana B.S.
        • Weinberger D.R.
        • et al.
        Planning ability in Parkinson’s disease is influenced by the COMT Val158Met polymorphism.
        Mov Disord. 2004; 19: 885-891
        • Gallinat J.
        • Bajbouj M.
        • Sander T.
        • Schlattmann P.
        • Xu K.
        • Ferro E.F.
        • et al.
        Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing.
        Biol Psychiatry. 2003; 54: 40-48
        • Glatt S.J.
        • Faraone S.V.
        • Tsuang M.T.
        Association between a functional catechol-o-methyltransferase gene polymorphism and schizophrenia.
        Am J Psychiatry. 2003; 160: 469-476
        • Gogos J.A.
        • Morgan M.
        • Luine V.
        • Ogawa S.
        • Pfaff D.
        • Karayiourgou M.
        Catechol-o-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behaviour.
        Proc Natl Acad Sci U S A. 1998; 95: 9991-9996
        • Goldberg T.E.
        • Egan M.F.
        • Gscheidle T.
        • Coppola R.
        • Weickert T.
        • Kolachana B.S.
        • et al.
        Executive subprocesses in working memory.
        Arch Gen Psychiatry. 2003; 60: 889-896
        • Goldman-Rakic P.S.
        • Castner S.A.
        • Svensson T.H.
        • Siever L.J.
        • Williams G.V.
        Targeting the dopamine D1 receptor in schizophrenia.
        Psychopharmacology (Berl). 2001; 174: 3-16
        • Goldman-Rakic P.S.
        • Muly III, E.C.
        • Williams G.V.
        D1 receptors in prefrontal cells and circuits.
        Brain Res Rev. 2000; 31: 295-301
        • Gothelf D.
        • Eliez S.
        • Thompson T.
        • Hinard C.
        • Penniman L.
        • Feinstein C.
        • et al.
        COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
        Nat Neurosci. 2005; 8: 1500-1502
        • Gothelf D.
        • Firsh A.
        • Munitz H.
        • Rockah R.
        • Aviram A.
        • Mozes T.
        • et al.
        Velocardiofacial manifestations and microdeletions in schizophrenic inpatients.
        A Med Genet (Neuropsychiatr Genet). 1997; 72: 455-461
        • Grace A.A.
        Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.
        J Neural Transm Gen Sect. 1993; 91: 111-134
        • Grace A.A.
        Gating of information flow within the limbic system and the pathophysiology of schizophrenia.
        Brain Res Brain Res Rev. 2000; 31: 330-341
        • Grossman M.H.
        • Creveling C.R.
        • Rybczynski R.
        • Braverman M.
        • Isersky C.
        • Breakefield X.O.
        Soluble and particulate forms of rat catechol-O-methyltransferase distinguished by gel electrophoresis and immune fixation.
        J Neurochem. 1985; 44: 421-432
        • Grossman M.H.
        • Emanuel B.S.
        • Budarf M.L.
        Chromosomal mapping of the human catechol-o-methyltransferase gene to 22q11.1 → 22q11.2.
        Genomics. 1992; 12: 822-825
        • Haber S.N.
        • Fudge J.L.
        The interface between dopamine neurons and the amygdala.
        Schizophr Bull. 1997; 23: 471-482
        • Hong J.
        • Shu-Leong H.
        • Tao X.
        • Lap-ping Y.
        Distribution of catechol-o-methyltransferase expression in human central nervous system.
        NeuroReport. 1998; 9: 2861-2864
        • Horowitz A.
        • Shifman S.
        • Rivlin M.
        • Pisanté A.
        • Darvasi A.
        A survey of the 22q11 microdeletion in a large cohort of schizophrenic patients.
        Schizophr Res. 2005; 73: 263-267
        • Huotari M.
        • Gogos J.A.
        • Karayiorou M.
        • Koponen O.
        • Forsberg M.
        • Raasmaja A.
        • et al.
        Brain catecholamine metabolism in catechol-o-methyltransferase (COMT)-deficient mice.
        Eur J Neurosci. 2002; 15: 246-256
        • Jiang H.
        • Xie T.
        • Ramsden D.B.
        • Ho S.L.
        Human catechol-O-methyltransferase down-regulation by estradiol.
        Neuropharmacology. 2003; 45: 1011-1018
        • Joober R.
        • Gauthier J.
        • Lal S.
        • Bloom D.
        • Lalonde P.
        • Rouleau G.
        • et al.
        Catechol-o-methyltransferase Val–108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test.
        Arch Gen Psychiatry. 2002; 59: 662-663
        • Karayiorgou M.
        • Altemus M.
        • Galke B.L.
        • Goldman D.
        • Murphy D.L.
        • Ott J.
        • et al.
        Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive–compulsive disorder.
        Proc Natl Acad Sci U S A. 1997; 94: 4572-4575
        • Karayiorgou M.
        • Morris M.A.
        • Morrow B.
        • Shprintzen R.J.
        • Goldberg R.
        • Borrow J.
        • et al.
        Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.
        Proc Natl Acad Sci U S A. 1995; 92: 7612-7616
        • Karhunen T.
        • Tilgmann C.
        • Ulmanen I.
        • Julkunen I.
        • Panula P.
        Distribution of catechol-o-methyltransferase enzyme in rat tissue.
        J Histochem Cytochem. 1994; 42: 1079-1090
        • Karoum F.
        • Chrapusta S.J.
        • Egan M.J.
        3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex.
        J Neurochem. 1994; 63: 972-979
        • Kastner A.
        • Anglade P.
        • Bounaix C.
        • Damier P.
        • Javoy-Agid F.
        • Bromet N.
        • et al.
        Immunohistochemical study of catechol-o-methyltransferase in the human mesostriatal system.
        Neuroscience. 1994; 62: 449-457
        • Kopin I.J.
        Catecholamine metabolism.
        Pharmacol Rev. 1985; 37: 333-364
        • Lachman H.M.
        • Papoulos D.F.
        • Saito T.
        • Yu Y.-M.
        • Szumlanski C.L.
        • Weinshilboum R.M.
        Human catechol-o-methyltransferase pharmacogenetics.
        Pharmacogenetics. 1996; 6: 243-250
        • Lavigne J.A.
        • Helzlsouer K.J.
        • Huang H.Y.
        • Strickland P.T.
        • Bell D.A.
        • Selmin O.
        • et al.
        An association between the allele coding for a low activity variant of catechol-o-methyltransferase and the risk for breast cancer.
        Cancer Res. 1997; 57: 5493-5497
        • Lewis C.M.
        • Levinson D.F.
        • Wise L.H.
        • DeLisi L.E.
        • Straub R.E.
        • Hovatta I.
        • et al.
        Genome scan meta-analysis of schizophrenia and bipolar disorder, part 2.
        Am J Hum Genet. 2003; 73: 34-48
        • Lewis D.A.
        • Melchiztky D.S.
        • Sesack S.R.
        • Whitehead R.E.
        • Auh S.
        • Sampson A.
        Dopamine transporter immunoreactivity in monkey cerebral cortex.
        J Comp Neurol. 2001; 432: 119-136
        • Li T.
        • Ball D.
        • Zhao J.
        • Murray R.M.
        • Liu X.
        • Sham P.C.
        • et al.
        Family-based linkage disequilibrium mapping using SNP marker haplotypes.
        Mol Psychiatry. 2000; 5: 77-84
        • Lotta T.
        • Vidgren J.
        • Tilgmann C.
        • Ulmanen I.
        • Melén K.
        • Julkunen I.
        • et al.
        Kinetics of human soluble and membrane-bound catechol-o-methyltransferase.
        Biochemistry. 1995; 34: 4202-4210
        • Lundström K.
        • Salminen M.
        • Jalanko A.
        • Savolainen R.
        • Ulmanen I.
        Cloning and characterization of human placental catechol-o-methyltransferase cDNA.
        DNA Cell Biol. 1991; 10: 181-189
        • Lundström K.
        • Tenhunen J.
        • Tilgmann C.
        • Karhunen T.
        • Panula P.
        • Ulmanen I.
        Cloning, expression and structure of catechol-o-methyltransferase.
        Biochim Biophys Acta. 1995; 16: 1-10
        • Maj J.
        • Rogóz Z.
        • Skuza G.
        • Sowinska H.
        • Superata J.
        Behavioural and neurochemical effects of Ro 40–7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson’s disease.
        J Neural Trans. 1990; 2: 101-112
        • Malholtra A.K.
        • Kestler L.J.
        • Mazzanti C.
        • Bates J.A.
        • Goldberg T.
        • Goldman D.
        A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.
        Am J Psychiatry. 2002; 159: 652-654
        • Männistö P.T.
        • Kaakkola S.
        Catechol-o-methyltransferase (COMT).
        Pharmacol Rev. 1999; 51: 593-628
        • Matsumoto M.
        • Shannon Weickert C.
        • Akil M.
        • Lipska B.K.
        • Hyde T.M.
        • Herman M.M.
        • et al.
        Catechol-o-methyltransferase mRNA expression in human and rat brain.
        Neuroscience. 2003; 116: 127-137
        • Matsumoto M.
        • Shannon Weickert C.
        • Beltaifa S.
        • Kolachana B.
        • Chen J.
        • Hyde T.M.
        • et al.
        Catechol-o-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.
        Neuropsychopharmacology. 2003; 28: 1521-1530
        • Mattay V.S.
        • Goldberg T.E.
        • Fera F.
        • Hariri A.R.
        • Tessitore A.
        • Egan M.F.
        • et al.
        Catechol o-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.
        Proc Natl Acad Sci U S A. 2003; 100: 6186-6191
        • Mattay V.S.
        • Tessitore A.
        • Callicott J.H.
        • Bertolino A.
        • Goldberg T.E.
        • Chase T.N.
        • et al.
        Dopaminergic modulation of cortical function in patients with Parkinson’s disease.
        Ann Neurol. 2002; 51: 156-164
        • Maynard T.M.
        • Haskell G.T.
        • Lieberman J.A.
        • LaMantia A.-S.
        22q11 DS.
        Int J Dev Neurosci. 2002; 20: 407-419
        • McTavish S.F.
        • Cowen P.J.
        • Sharp T.
        Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.
        Psychopharmacology (Berl). 1999; 141: 182-188
        • Meyer-Lindenberg A.
        • Kohn P.D.
        • Kolachana B.
        • Kippenham S.
        • McInerney-Leo A.
        • Nussbaum R.
        • et al.
        Midbrain dopamine and prefrontal function in humans.
        Nat Neurosci. 2005; 8: 594-596
        • Miner L.H.
        • Schroeter S.
        • Blakeley R.D.
        • Sesack S.R.
        Ultrastructural localization of the norepinephine transporter in the superficial and deep layers in the rat prelimbic prefrontal cortex and its relationship to probable dopamine terminals.
        J Comp Neurol. 2003; 466: 478-494
        • Munafo M.R.
        • Bowes L.
        • Clark T.G.
        • Flint J.
        Lack of association of the COMT (Val158/108 Met) gene and schizophrenia.
        Mol Psychiatry. 2005; 10: 765-770
        • Murphy K.C.
        • Jones L.A.
        • Owen M.J.
        High rates of schizophrenia in adults with velo-cardio-facial syndrome.
        Arch Gen Psychiatry. 1999; 56: 940-945
        • Napolitano A.
        • Bellini G.
        • Borroni E.
        • Zürcher G.
        • Bonuccelli U.
        Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine.
        Parkinsonism Relat Disord. 2003; 9: 145-150
        • Nicodemus K.K.
        • Straub R.E.
        • Egan M.F.
        • Weinberger D.R.
        Evidence for statistical epistasis between (COMT) Val158Met polymorphism and multiple putative schizophrenia susceptibility genes.
        Am J Med Genet. 2005; 138B: 130-131
        • Nolan K.A.
        • Bilder R.M.
        • Lachman H.M.
        • Volavka J.
        Catechol-o-methyltransferase Val158Met polymorphism in schizophrenia.
        Am J Psychiatry. 2004; 161: 359-361
        • Palmitier M.A.
        • Kang A.M.
        • Kidd K.K.
        Global variation in the frequencies of functionally different catechol-o-methyltransferase alleles.
        Biol Psychiatry. 1999; 46: 557-567
        • Paylor R.
        • McIlwain K.L.
        • McAninch R.
        • Nellis A.
        • Yuva-Paylor L.A.
        • Baldini A.
        • et al.
        Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments.
        Hum Mol Genet. 2001; 10: 2645-2650
        • Raxworthy M.J.
        • Gulliver P.A.
        • Hughes P.J.
        The cellular location of catechol-O-methyltransferase in rat liver.
        Naunyn Schmiedebergs Arch Pharmacol. 1982; 320: 182-188
        • Rosenberg D.R.
        • Lewis D.A.
        Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices.
        J Comp Neurol. 1995; 358: 383-400
        • Roth J.A.
        Membrane-bound catechol-o-methyltransferase.
        Rev Physiol Biochem Pharmacol. 1992; 120: 1-29
        • Sasaki M.
        • Kaneuchi M.
        • Sakuragi N.
        • Dahiya R.
        Multiple promoters of catechol-o-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
        Cancer Res. 2003; 63: 3101-3106
        • Sawaguchi T.
        • Goldman-Rakic P.S.
        D1 dopamine receptors in prefrontal cortex.
        Science. 1991; 251: 947-950
        • Seamans J.K.
        • Yang C.R.
        The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
        Prog Neurobiol. 2004; 74: 1-58
        • Sesack S.R.
        • Hawrylak V.A.
        • Matus C.
        • Guido M.A.
        • Levey A.I.
        Dopamine axon varicositites in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.
        J Neurosci. 1998; 18: 2697-2708
        • Shifman S.
        • Bronstein M.
        • Sternfeld M.
        • Pisante-Shalom A.
        • Lev-Lehman E.
        • Weizman A.
        • et al.
        A highly significant association between a COMT haplotype and schizophrenia.
        Am J Hum Genet. 2002; 71: 1296-1302
        • Shprintzen R.J.
        • Goldberg R.B.
        • Lewin M.L.
        • Sidoti E.J.
        • Berkman M.D.
        • Argamaso R.V.
        • et al.
        A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities.
        Cleft Palate J. 1978; 5: 56-62
        • Smolka M.N.
        • Schumann G.
        • Wrase J.
        • Grüsser S.M.
        • Flor H.
        • Mann K.
        • et al.
        J Neurosci. 2005; 25: 836-842
        • Stefanis N.C.
        • Van Os J.
        • Avramopoulos D.
        • Smyrnis N.
        • Evdokimidis I.
        • Hantoumi I.
        • et al.
        Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition.
        Biol Psychiatry. 2004; 56: 510-515
        • Sweet R.A.
        • Devlin B.
        • Pollock B.G.
        • Sukonick D.L.
        • Kastango K.B.
        • Bacanu S.A.
        • et al.
        Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
        Mol Psychiatry. 2005; 10: 1026-1036
        • Tenhunen J.
        • Salminen M.
        • Lundström K.
        • Kiviluoto T.
        • Savolainen R.
        • Ulmanen I.
        Genomic organization of the human catechol-o-methyltransferase gene and its expression from two distinct promoters.
        Eur J Biochem. 1994; 223: 1049-1059
        • Thierry A.-M.
        • Tassin J.P.
        • Blanc G.
        • Glowinski J.
        Selective activation of the mesocortical dopamine system by stress.
        Nature. 1976; 263: 242-244
        • Tunbridge E.M.
        • Bannerman D.M.
        • Sharp T.
        • Harrison P.J.
        Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.
        J Neurosci. 2004; 24: 5331-5335
        • Tunbridge E.
        • Burnet P.W.
        • Sodhi M.S.
        • Harrison P.J.
        Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex of schizophrenia, bipolar disorder and major depression.
        Synapse. 2004; 51: 112-118
        • Tunbridge E.M.
        • Weickert C.S.
        • Kleinman J.E.
        • Herman M.M.
        • Chen J.
        • Kolachana B.S.
        • et al.
        Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal life span program no. 675.17.
        2005 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC2005 (2005. Online.)
      2. Tunbridge EM, Weinberger DR, Harrison PJ (in press): A novel protein isoform of catechol O-methyltransferase (COMT): Brain expression analysis in schizophrenia and bipolar disorder and effect of Val(158)Met genotype. Mol Psychiatry.

        • Ulmanen I.
        • Peränen J.
        • Tenhunen J.
        • Tilgmann C.
        • Karhunen T.
        • Panula P.
        • et al.
        Expression and intracellular localisation of catechol-o-methyltransferase in transfected mammalian cells.
        Eur J Biochem. 1997; 243: 452-459
        • Weickert T.W.
        • Goldberg T.E.
        • Mishara A.
        • Apud J.A.
        • Kolachana B.S.
        • Egan M.F.
        • et al.
        Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
        Biol Psychiatry. 2004; 56: 677-682
        • Weinberger D.R.
        Implications of normal brain development for the pathogenesis of schizophrenia.
        Arch Gen Psychiatry. 1987; 44: 660-668
        • Weinberger D.R.
        • Egan M.F.
        • Bertolino A.
        • Callicott J.H.
        • Mattay V.S.
        • Lipska B.K.
        • et al.
        Prefrontal neurons and the genetics of schizophrenia.
        Biol Psychiatry. 2001; 50: 825-844
        • Williams G.V.
        • Goldman-Rakic P.S.
        Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.
        Nature. 1995; 376: 572-575
      3. Winterer G, Egan MF, Kolachana BS, Goldberg TE, Coppola R, Weinberger DR (in press): Prefrontal electrophysiological “noise” and COMT genotype in schizophrenia. Biol Psychiatry.

        • Winterer G.
        • Weinberger D.R.
        Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.
        Trends Neurosci. 2004; 27: 683-690
        • Woo J.M.
        • Yoon K.S.
        • Choi Y.H.
        • Oh K.S.
        • Lee Y.S.
        • Yu B.H.
        The association between panic disorder and the L/L genotype of catechol-O-methyltransferase.
        J Psychiatr Res. 2004; 38: 365-370
        • Xie T.
        • Ho S.L.
        • Ramsden D.B.
        Characterization and implications of estrogenic down-regulation of human catechol-o-methyltransferase gene transcription.
        Mol Pharmacol. 1999; 56: 31-38
        • Yan W.
        • Jacobsen L.K.
        • Krasnewich D.M.
        • Guan X.-Y.
        • Lenane M.C.
        • Paul S.P.
        • et al.
        Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired.”.
        Am J Med Genet B Neuropsychiatr Genet. 1998; 81: 41-43
        • Zahrt J.
        • Taylor J.R.
        • Mathew R.G.
        • Arnsten A.F.T.
        Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.
        J Neurosci. 1997; 17: 8528-8535
        • Zubieta J.K.
        • Heitzeg M.M.
        • Smith Y.R.
        • Bueller J.A.
        • Xu K.
        • Xu Y.
        • et al.
        COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.
        Science. 2003; 299: 1240-1243